CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleLevered free cash flow is $44.85M, above the global median of $16.24M
- PositionP/E ratio is 419.67×, higher than 95% of its Diagnostics & Research peers (median 52.5×)
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.38%
Annual Rate
CNY 0.18Paid unknown
Payback Period
63.9 yr
Last Ex-Dividend
Jun 8, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.57BCNY678.13M · vs all stocks (USD)
Trailing P/E
419.67xvs Diagnostics & Research peers
Revenue (TTM)
1.38BCNY205.60M · vs all stocks (USD)
Profit Margin
1.03%vs Diagnostics & Research peers
Beta
0.5040xvs all stocks
52-Week Change
20.82%vs all stocks
Market Capitalization
4.57BCNY678.13M · vs all stocks (USD)
Enterprise Value
4.65BCNY690.44M · vs all stocks (USD)
Trailing P/E
419.67xvs Diagnostics & Research peers
Price to Sales (TTM)
3.64xvs Diagnostics & Research peers
Price to Book (MRQ)
3.16xvs Diagnostics & Research peers
Enterprise to Revenue
3.36xvs Diagnostics & Research peers
Enterprise to EBITDA
38.98xvs Diagnostics & Research peers
Gross Margin
27.33%vs Diagnostics & Research peers
Profit Margin
1.03%vs Diagnostics & Research peers
Operating Margin
13.31%vs Diagnostics & Research peers
Return on Assets (TTM)
1.43%vs Diagnostics & Research peers
Return on Equity (TTM)
1.80%vs Diagnostics & Research peers
Revenue (TTM)
1.38BCNY205.60M · vs all stocks (USD)
Revenue per Share (TTM)
3.59CNYUpdated Aug 20, 2026Quarterly Revenue Growth
-16.99%vs Diagnostics & Research peers
Gross Profit (TTM)
351.34MCNY52.18M · vs all stocks (USD)
EBITDA (TTM)
116.60MCNY17.32M · vs all stocks (USD)
Net Income (TTM)
14.25MCNY2.12M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-31.98%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
369.33MCNY54.85M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
301.97MCNY44.85M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1800CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
1.38%vs all stocks
Minority Interest (Equity)
96.35MCNYFY2025 · Dec 31, 2025Revenue
1.45BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.10BCNYFY2025 · Dec 31, 2025Gross Profit
346.98MCNYFY2025 · Dec 31, 2025Operating Income
29.56MCNY4.39M · vs all stocks (USD)
Pre-tax Income
10.53MCNYFY2025 · Dec 31, 2025Income Tax Expense
25.95MCNYFY2025 · Dec 31, 2025Net Income
-15.42MCNYFY2025 · Dec 31, 2025EBIT
16.95MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
116.60MCNYFY2025 · Dec 31, 2025Research & Development
41.05MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
75.32MCNYFY2025 · Dec 31, 2025Other Operating Expenses
5.75MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
6.12MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
6.41MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.0800CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.0800CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
384.33MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
384.33MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-15.42MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-15.32MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
179.15MCNYFY2025 · Dec 31, 2025Free Cash Flow
128.50MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
697.96MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-15.42MCNYFY2025 · Dec 31, 2025Other Non-cash Items
30.31MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
117.95MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
46.32MCNYFY2025 · Dec 31, 2025Capital Expenditures
-50.65MCNYFY2025 · Dec 31, 2025Net Acquisitions
3.52MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.99BCNYFY2025 · Dec 31, 2025Sale of Investments
1.91BCNYFY2025 · Dec 31, 2025Other Investing Activity
6.45KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-122.88MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
50.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-135.80MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-92.70MCNYFY2025 · Dec 31, 2025Other Financing Charges
-15.31MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-193.81MCNYFY2025 · Dec 31, 2025Shares Outstanding
400.52MSharesUpdated Aug 20, 2026Float Shares
165.17MSharesUpdated Aug 20, 2026% Held by Insiders
59.29%vs all stocks
% Held by Institutions
1.36%vs all stocks
Total Cash (MRQ)
409.02MCNY60.75M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.03CNYUpdated Aug 20, 2026Total Debt (MRQ)
158.10MCNY23.48M · vs all stocks (USD)
Current Ratio (MRQ)
3.26xvs Diagnostics & Research peers
Book Value per Share (MRQ)
3.98CNYUpdated Aug 20, 2026Total Assets
2.29BCNY340.44M · vs all stocks (USD)
Total Current Assets
1.75BCNYFY2025 · Dec 31, 2025Total Liabilities
647.39MCNYFY2025 · Dec 31, 2025Total Non-current Assets
540.40MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
116.21MCNYFY2025 · Dec 31, 2025Total Current Liabilities
531.18MCNYFY2025 · Dec 31, 2025Cash
759.44MCNYFY2025 · Dec 31, 2025Cash Equivalents
58.99KCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
759.50MCNYFY2025 · Dec 31, 2025Accounts Receivable
682.91MCNYFY2025 · Dec 31, 2025Inventory
269.81MCNYFY2025 · Dec 31, 2025Accounts Payable
402.62MCNYFY2025 · Dec 31, 2025Short-term Debt
62.06MCNYFY2025 · Dec 31, 2025Other Current Liabilities
290.08KCNYFY2025 · Dec 31, 2025Long-term Debt
109.38MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
120.00KCNYFY2025 · Dec 31, 2025Common Stock (Book)
400.52MCNYFY2025 · Dec 31, 2025Retained Earnings
530.33MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.64BCNY244.29M · vs all stocks (USD)
Treasury Stock
23.01MCNYFY2025 · Dec 31, 202552-Week Low
7.86CNYUpdated Aug 20, 202652-Week High
14.55CNYUpdated Aug 20, 202652-Week Change
20.82%vs all stocks
Beta
0.5040xvs all stocks
50-Day MA
8.99CNYUpdated Aug 20, 2026200-Day MA
10.05CNYUpdated Aug 20, 2026Avg 10-Day Volume
31.03MSharesUpdated Aug 20, 2026Avg 30-Day Volume
16.62MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.0300CNYUpdated Aug 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
P/E ratio is 419.67×, higher than 95% of its Diagnostics & Research peers (median 52.5×)Significant
P/E ratio: 419.667Industry median: 52.50Industry P95: 194.882Peers compared: 31.00
Financial Health
Altman Z-Score 5.85: safe zoneNotable
Altman Z-Score: 5.85
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Levered free cash flow is $44.85M, above the global median of $16.24MNotable
Levered free cash flow (USD): 44,848,320.628Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Ishihara Sangyo Kaisha, Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Yiwu Huading Nylon Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Jihua Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Dongguan Changlian New Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Hangzhou Jizhi Mechatronic Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Suntront Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Sk Discovery Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
2CRSI S.A.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Ocean's King Lighting Science & Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Wuxi New Hongtai Electrical Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule